3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
11
Lung Neoplasms
8
Neoplasms
7
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Melanoma
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Hematologic Neoplasms
4
Esophageal Neoplasms
4
Multiple Myeloma
3
Carcinoma, Renal Cell
3
COVID-19
3
Barrett Esophagus
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Papillomavirus Infections
2
Ovarian Neoplasms
2
Leukemia, Myeloid, Acute
2
Genetic Predisposition to Disease
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Adenocarcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Interventions
Fluorodeoxyglucose F18
3
Blood Specimen Collection
2
trifluridine tipiracil drug combination
1
tegafur-gimeracil-oteracil
1
Tegafur
1
Surveys and Questionnaires
1
Specimen Handling
1
S 1 (combination)
1
Radiomics
1
Proton Therapy
1
Postmortem Imaging
1
PMEPA1 protein, human
1
Off-Label Use
1
Latent Class Analysis
1
Immunohistochemistry
1
Histocompatibility Testing
1
Hepatitis B Vaccines
1
Fluorouracil
1
Capecitabine
1
Blood Component Removal
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Solid Tumor
×
Specimen Handling
×
Clear all
NCT07137312
2025-12-23
Ex Vivo Expansion (ACT-X)
Mayo Clinic
Recruiting
24 enrolled